5SGQ

Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamino)pyrazine-2-carboxylic acid

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2010-07-18
Detector	PSI PILATUS 6M
Wavelength(s)	1.000000
Spacegroup name	H 3
Unit cell lengths	135.496, 135.496, 235.736
Unit cell angles	90.00, 90.00, 120.00

Refinement procedure

Resolution	43.590 - 2.040
R-factor	0.1795
Rwork	0.177
R-free	0.22440
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.015
RMSD bond angle	2.024
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.8.0258)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	43.590	43.590	2.090
High resolution limit [Å]	2.040	9.120	2.040
Rmerge	0.091	0.025	1.496
Rmeas	0.102	0.028	1.677
Total number of observations	536177
Number of reflections	102765	1142	7670
<I/σ(I)>	13	50	1.25
Completeness [%]	100.0	99	100
Redundancy	5.218	5.196	4.922
CC(1/2)	0.999	0.999	0.400

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7.5	295	5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2